Evidence map›Paper›PMID 37007156›Full record

ArticleFrontiers in oncology2023

An MRI-based radiomics nomogram in predicting histologic grade of non-muscle-invasive bladder cancer.

Longchao Li, Jing Zhang, Xia Zhe, Hongzhi Chang, Min Tang, Xiaoyan Lei, Li Zhang, Xiaoling Zhang

Abstract read
In one paragraph

Article in Frontiers in oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Longchao LiDepartment of MRI, Shaanxi Provincial People's Hospital, Xi'an, Shaanxi, China.
Jing ZhangDepartment of MRI, Shaanxi Provincial People's Hospital, Xi'an, Shaanxi, China.
Xia ZheDepartment of MRI, Shaanxi Provincial People's Hospital, Xi'an, Shaanxi, China.
Hongzhi ChangDepartment of MRI, Shaanxi Provincial People's Hospital, Xi'an, Shaanxi, China.
Min TangDepartment of MRI, Shaanxi Provincial People's Hospital, Xi'an, Shaanxi, China.
Xiaoyan LeiDepartment of MRI, Shaanxi Provincial People's Hospital, Xi'an, Shaanxi, China.
Li ZhangDepartment of MRI, Shaanxi Provincial People's Hospital, Xi'an, Shaanxi, China.
Xiaoling ZhangDepartment of MRI, Shaanxi Provincial People's Hospital, Xi'an, Shaanxi, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Non-muscle-invasive bladder cancer (NMIBC) is categorized into high and low grades with different clinical treatments and prognoses. Thus, accurate preoperative evaluation of the histologic NMIBC grade through imaging techniques is essential. Objectives: To develop and validate an MRI-based radiomics nomogram for individualized prediction of NMIBC grading. Methods: The study included 169 consecutive patients with NMIBC (training cohort: n = 118, validation cohort: n = 51). A total of 3148 radiomic features were extracted, and one-way analysis of variance and least absolute shrinkage and selection operator were used to select features for building the radiomics score(Rad-score). Three models to predict NMIBC grading were developed using logistic regression analysis: a clinical model, a radiomics model and a radiomics-clinical combined nomogram model. The discrimination and calibration power and clinical applicability of the models were evaluated. The diagnostic performance of each model was compared by determining the area under the curve (AUC) in receiver operating characteristic (ROC) curve analysis. Results: A total of 24 features were used to build the Rad-score. A clinical model, a radiomics model, and a radiomics-clinical nomogram model that incorporated the Rad-score, age, and number of tumors were constructed. The radiomics model and nomogram showed AUCs of 0.910 and 0.931 in the validation set, which outperformed the clinical model (0.745). The decision curve analysis also showed that the radiomics model and combined nomogram model yielded higher net benefits than the clinical model. Conclusion: A radiomics-clinical combined nomogram model has the potential to be used as a non-invasive tool for the differentiating low-from high-grade NMIBCs.

Indexed as

gradeMRInomogramnon-muscle-invasive bladder cancerradiomics

Identifiers

PMID37007156
PMCPMC10060523

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.